Press coverage about Genesis Healthcare (NYSE:GEN) has trended somewhat positive recently, Accern reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Genesis Healthcare earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned news articles about the company an impact score of 46.0755499123002 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

Genesis Healthcare (NYSE GEN) opened at 1.08 on Friday. The company’s market cap is $102.30 million. Genesis Healthcare has a 52-week low of $0.95 and a 52-week high of $4.75. The company’s 50 day moving average price is $1.29 and its 200 day moving average price is $2.11.

Several research firms recently commented on GEN. Cantor Fitzgerald began coverage on Genesis Healthcare in a research report on Wednesday, July 5th. They set an “overweight” rating for the company. ValuEngine upgraded Genesis Healthcare from a “strong sell” rating to a “sell” rating in a research report on Thursday, June 8th.

TRADEMARK VIOLATION NOTICE: This article was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at

About Genesis Healthcare

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Stock Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related stocks with our FREE daily email newsletter.